Evaluation of the Safety and Performance of the Neocement® Inject P
Evaluation of the Safety and Performance of the Neocement® Inject P: A Prospective Observational Study in Orthopaedic Area
Bioceramed
80 participants
Sep 5, 2025
OBSERVATIONAL
Conditions
Summary
This study aims to collect real-world clinical data to gather information on the performance and safety of the Neocement® Inject P when used according to its intended purpose and current clinical applications. The results of the clinical study will serve as clinical evidence for the device's clinical evaluation, targeting submission to the new Medical Device Regulation (EU) 2017/745.
Eligibility
Inclusion Criteria5
- Adult males or females (age \> 18 years old);
- Patients with bone defect treatment who meet predefined criteria in Instructions For Use (IFU) of Neocement® Inject P;
- Patients who are able to sign an informed consent form (for data collection)
- Patients with bone defects, which may be surgically created or result from traumatic injury to the bone;
- Patients with bone skeletal defects that are not intrinsic to the stability of the bone structure or with a site that can be stabilized;
Exclusion Criteria9
- Patients who are unable to understand consent and the objectives of the study;
- Signs of local or systemic acute/ active or chronic infections;
- Metabolic affections;
- Severe degenerative diseases, conditions in which general bone grafting is not advisable;
- Implementation sites that allow product migration;
- Conditions which require structural support in the skeletal system;
- Conditions where the implantation site is unstable and not rigidly fixated;
- Sensibility to the implantable materials;
- Known hypersensitivity to the implant material.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06973239